Next Article in Journal
Concomitant Surgical Ablation Using a Novel Bipolar Radiofrequency Clamp: Outcomes from the TRAC-AF Registry
Previous Article in Journal
Prevalence of Psoriatic Arthritis in Patients with Moderate-to-Severe Psoriasis in the Era of Biologics and Small Molecule Therapies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impact of 50 g OGTT-Induced Acute Hyperglycemia on Uteroplacental and Fetoplacental Circulations in Gestational Diabetes Screening: A Prospective Single-Center Study

by
Hilal Gülsüm Turan Özsoy
,
Gültekin Adanaş Aydın
*,
Serhat Ünal
and
Behiye Oral
Bursa City Hospital, 16110 Bursa, Turkey
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(23), 8362; https://doi.org/10.3390/jcm14238362
Submission received: 24 August 2025 / Revised: 29 October 2025 / Accepted: 17 November 2025 / Published: 25 November 2025
(This article belongs to the Section Obstetrics & Gynecology)

Abstract

Background: Gestational diabetes screening often employs the 50 g oral glucose tolerance test (OGTT), which induces acute hyperglycemia. This study aimed to investigate the effects of this acute hyperglycemia on uteroplacental and fetoplacental circulations in women between the 24th and 28th weeks of pregnancy using Doppler ultrasonography (USG). Methods: This prospective, single-center study included 209 pregnant women with singleton pregnancies followed at Bursa City Hospital between January and April 2021. Doppler USG measurements were taken before and 60 min after administering the 50 g OGTT. Venous blood samples were collected to measure blood glucose levels pre-test and one hour post-test. Doppler indices, including the pulsatility index (PI), resistive index (RI), and systolic/diastolic ratio (S/D) for the uterine arteries, umbilical artery (UA), and middle cerebral artery (MCA), were recorded and converted to Z scores based on gestational age. Fetal biometric parameters, including abdominal circumference (AC), femur length (FL), and biparietal diameter (BPD), were also measured. Results: The study found a significant decrease in the mean MCA-PI, MCA RI, MCA S/D, and cerebroplacental ratio (CPR) values, as well as their respective Z scores, in the post-test measurements compared to pre-test values (p < 0.001 for all). No significant differences were observed in the S/D, RI, PI values, or Z scores of the uterine arteries and UA between pre-test and post-test measurements. Conclusions: Acute hyperglycemia induced by the 50 g OGTT significantly affects fetal cerebral circulation, evidenced by decreased MCA-PI, MCA RI, MCA S/D, and CPR values, but does not significantly impact uteroplacental circulation. Further large-scale studies are necessary to explore the effects of varying maternal glucose levels and the chronic impacts of non-physiological glucose levels on placental circulation.

1. Introduction

In obstetrics, Doppler ultrasonography (USG) is widely used as a reliable examination method to assess fetal well-being, which depends on several factors, including maternal nutritional intake, maternal body composition, uteroplacental and fetoplacental blood flow, placental transfer and nutrient metabolism.
The relationship between placental insufficiency and possible outcomes such as perinatal death, intrauterine growth retardation (IUGR), and preeclampsia (PE) reveals the importance of Doppler USG in obstetrics.
Given the increase in the distribution of cardiac output towards the brain (cerebral redistribution) during fetal hypoxia, Doppler USG can assess the response of the relevant organ to fetal hypoxia. Increased cerebral blood flow leads to a decrease in the middle cerebral artery (MCA) resistive index (RI) and an increase in the umbilical artery (UA) RI, a phenomenon known as the brain-sparing effect [1,2,3]. A decrease in the cerebroplacental ratio (CPR), calculated by dividing the MCA pulsatility index (PI) by the UA PI, is an early indicator of fetal hypoxia and is associated with adverse pregnancy outcomes and the need for therapeutic delivery in term fetuses [4,5].
The UA PI assesses placental functionality, with higher resistance being associated with placental insufficiency and intrauterine growth retardation [6]. Both uteroplacental and fetoplacental circulations can be evaluated via Doppler USG scans of the uterine and umbilical arteries. CPR effectively reflects placental health and fetal response.
Transport of glucose, the primary energy source for the fetus, across the placenta via facilitated diffusion depends on the mother’s blood sugar levels and placental blood flow [7]. Some studies assessing Doppler indices before and after oral glucose tolerance test (OGTT) reported a decrease in MCA-PI, while others reported no significant change [7,8,9,10]. Similarly, some studies reported no significant change in UA-PI after OGTT, while others reported an increase or decrease [7,8,9,10].
In light of this information, this study was conducted to investigate the impact of acute hyperglycemia induced by 50-g OGTT, which is commonly used for gestational diabetes screening, on uteroplacental and fetoplacental circulations in women between the 24th and 28th weeks of gestation, using Doppler USG.

2. Materials and Methods

2.1. Study Design

This study was designed as a prospective single-center study. The study protocol was approved by the Bursa City Hospital Ethics Committee (Decision No: 2021-11/3). The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Written informed consent was obtained from the participants included in the study.

2.2. Population and Sample

The study population consisted of women between the 24th and 28th weeks of pregnancy who had singleton pregnancies followed at Bursa City Hospital Obstetrics and Gynecology and Radiology Clinics between 18 June 2021–18 August 2021. Demographic and clinical characteristics of the patients, including maternal age, parity, gravidity, abortion history, gestational diabetes history, familial diabetes mellitus (DM) history, presence of systemic diseases, smoking history, gestational age, and last menstrual period, were recorded. The gestational age of participants whose last menstrual period was unknown was determined based on the crown-rump length (CRL) obtained from USG measurements carried out in the first trimester. Patients with hypertension, DM, renal and endocrinological diseases, those using drugs that could affect fetoplacental and uteroplacental Doppler indices, those with fetal anomalies, and those with multiple pregnancies were excluded from the study. Patients with normal fasting blood glucose levels and without impaired glucose tolerance in the first trimester were included in the study. In the end, the study sample consisted of 209 women.

2.3. OGTT and Doppler USG Procedures

All participants underwent 50-g OGTT as part of gestational diabetes screening. Venous blood samples were taken from the patients, and their blood sugar levels were measured twice before the test (first measurement) and one hour after the test (second measurement).
Doppler USG scans were performed while the patients were on an empty stomach, rested, and remained seated at 08:30 a.m. before OGTT and 60 min after the OGTT. All Doppler USG scans were conducted by a radiologist with 13 years of experience in Doppler USG, using a Voluson E8 (GE Healthcare, Austria GmbH &. Co OG, Tiefenbach, Austria) device equipped with an electronic matrix convex probe (2–9 MHz).
Intra-observer reliability results showed high agreement between right and left uterine artery measurements (p < 0.0001, Table 1).

2.4. Analysis of Doppler Waves

Within the scope of the analysis of Doppler waves, the uterine artery, UA, and MCA indices shown below, calculated independently of the angle of the sound wave or flow angle, were measured.
The UA parameters were measured at the free loop of the umbilical cord in the absence of respiration or fetal movement. During each measurement, 10 to 15 waveforms were evaluated in three consecutive waveforms. The MCA parameters were measured at the proximal MCA of the cerebral hemisphere closer to the probe, at the starting point close to the circle of Willis. The CPR was calculated. The MCA and UA Doppler indices were measured at a fetal heart rate (FHR) of 130–150 bpm. Uterine artery Doppler assessment, each artery was identified using color flow mapping at the crossover with the external iliac artery. All Doppler indices were measured per the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) guidelines [11]. Measurements were made with an insonation angle of less than 30°, avoiding any maternal or fetal movement. At least three consecutive waveforms or a 10-s automatic trace were used for umbilical vein (UV) flow. Measurements were not performed after uterine contractions or fetal deceleration to avoid potential pathological waveforms [12].
Since Doppler indices can vary with gestational age, the values were converted to Z scores. The Z scores, calculated using the formula of observed value—expected value for gestational age/standard deviation (SD) for gestational age, represent the deviation from the mean in units of SD [13,14]. The Z scores for MCA-PI, UA-PI, CPR, and uterine artery-PI were calculated electronically (https://fetalmedicine.org/research/doppler, accessed on 14 May 2025). Participants’ fetal biometric parameters, such as abdominal circumference (AC), femur length (FL), and biparietal diameter, were also measured.

2.5. Statistical Analysis

Statistical analyses were conducted using SPSS software, version 22.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were presented as mean ± standard deviation (SD), interquartile range (IQR), as well as absolute numbers and percentages where appropriate. The distribution of continuous variables was assessed by applying the Kolmogorov–Smirnov test in both the first and second measurements in order to determine whether the data conformed to a normal distribution. For comparisons between the left and right indices obtained during the initial and subsequent measurements, the Wilcoxon signed-rank test was employed, given its suitability for paired non-parametric data. In addition, the associations between measurement outcomes and quantitative variables were examined using Spearman’s rank correlation analysis, which is particularly appropriate for evaluating monotonic relationships without assuming normality. A p-value of less than 0.05 was accepted as the threshold for statistical significance throughout the analysis.

3. Results

A total of 209 pregnant women with a mean age of 28.7 ± 5.38 (min. 19, max. 41) years were included in the study (Table 2). Of the 209 participants, 23 (11%) had a systemic disease history (3 patients with asthma, 1 patient with Behçet’s disease, and 7 patients with hypothyroidism), 28 (13.4%) had smoking history, 15 (7.2%) had regular drug use, 63 (30.1%) had familial DM history, 5 (2.4%) had a history of DM in a previous pregnancy, 7 (3.4%) had a history of preeclampsia, 11 (5.3%) had a history of IUGR in an earlier pregnancy and 10 (4.8%) had a history of preterm delivery (Table 3).
There was no significant difference in the right and left uterine artery S/D, RI, PI values, and PI-Z scores between the first and second measurements (right uterine artery; p = 0.107, p = 0.437, p = 0.189, and p = 0.412, respectively, and left uterine artery; p = 0.375, p = 0.566, p = 0.387, and p = 0.464, respectively). Given the lack of significant difference in the right and left uterine artery S/D, RI, PI values, and PI-Z scores between the first and second measurements, the mean values of the uterine artery indices were compared between the first and second measurements. However, no significant difference was found in mean S/D, RI, PI values, or PI-Z scores of the uterine artery between the first and second measurements (p = 0.129, p = 0.411, p = 0.200, and p = 0.284, respectively).
There was also no significant difference in UA’s S/D, RI, PI values, or PI-Z scores between the first and second measurements (p = 0.898, p = 0.900, p = 0.901, and p = 0.947, respectively).
The mean MCA/PI, MCA RI, MCA S/D, CPR values, MCA/PI, and CPR Z scores obtained from the second measurement were significantly lower than those obtained from the first measurement (p < 0.001, p < 0.001, p < 0.001, p = 0.004, p < 0.001, and p = 0.003, respectively) (Table 4).
Patients with a 50 g glucose challenge test result of ≥140 mg/dL underwent the 100 g OGTT. Doppler ultrasonography parameters of patients with a 50 g glucose test ≥140 mg/dL were compared. The comparison of patients with positive (n = 62) and negative (n = 147) screening results is presented in Table 5. Examination of Table 5 shows that in patients with a positive screening test, left uterine artery PI, RI, and S/D values decreased in the second measurements, whereas in patients with a negative screening test, these values increased. No significant differences were observed between measurements for other Doppler parameters outside of the left uterine artery.
Similarly, Table 6 presents the comparison of patients with positive (n = 7) and negative (n = 174) results of the 100 g OGTT. In patients with a positive OGTT result, left uterine artery PI, RI, and S/D values decreased in the second measurements, whereas in patients with a negative result, these values increased. No significant differences were observed for other Doppler parameters outside of the left uterine artery.

4. Discussion

This study investigated the impact of acute hyperglycemia induced by 50-g OGTT, used for gestational diabetes screening, on fetoplacental and uteroplacental circulation in women between the 24th and 28th weeks of gestation using Doppler USG. Consequently, it was found that mean MCA/PI, MCA RI, MCA S/D, CPR values, MCA/PI, and CPR Z scores values obtained from the second measurement (after OGTT) were significantly lower than those obtained from the first measurement (before OGTT).
In a study in which UA and MCA velocity waveforms were measured using Doppler USG before and two hours after the 75-g OGTT in 105 low-risk pregnant women between the 30th and 32nd weeks of gestation, Haugen et al. found that the MCA-PI decreased significantly following the OGTT, independently of the fetal heart rate (FHR). They also reported that the UA-PI value decreased significantly after the test; however, they noted that these changes were related to FHR [7]. They concluded that the maternal glucose challenge test can reduce fetal cerebral blood flow impedance, regardless of fetal size.
In another study, Opheim and colleagues [15] investigated the effect of maternal nutrition on Doppler blood flow velocity variables in 89 women between the 30th and 36th weeks of gestation with normal singleton pregnancies. They performed the first measurements, including UA-PI, MCA-PI, PSV, and FHR, at 08:30 a.m. while the patients were on an empty stomach. The participants were then given a standard breakfast with approximately 400 kcal of energy content. The second measurements were performed 105 min after breakfast. Consequently, they found that the fetal MCA-PI value had decreased significantly, independent of the FHR. They did not report any significant postprandial change in the UA-PI value, except for male fetuses at 30 weeks. On the other hand, they reported a significant postprandial decrease in CPR value and a significant increase in the MCA-PSV value [7].
In a study investigating the impact of glucose on Doppler flow velocity in the MCA and UA of 24 healthy pregnant women between the 36th and 40th weeks of gestation, Gillis et al. [8] found a significant decrease in the RI value of both arteries after glucose challenge test. In a study investigating fetal MCA and UA blood flow before and after the 50-g OGTT in pregnant women, Pardo et al. [16] found a significant decrease in MCA-RI value and a significant increase in UA-RI value.
Zahid et al. conducted a study involving 25 participants at 36 weeks of gestation, dividing them into two groups. Doppler ultrasonography measurements were performed at approximately 8:30 a.m. while all participants were fasting. One group was provided a 400 kcal breakfast, whereas the other group remained fasting. After 1–3 days, the groups were switched, and measurements were repeated. The MCA PI and UA PI values, both adjusted and unadjusted for fetal heart rate (FHR), did not differ significantly between the two meal states. This study is noteworthy, as it included a control group—unlike many previous reports—and the authors attributed the absence of significant differences in MCA PI values between groups to diurnal variations [17].
In our study, because Doppler parameters are known to be affected by FHR, fetal respiration, and movements, all measurements were performed during periods when the fetus was more stable. However, adjusted comparisons considering FHR were not performed. Instead, the measurements were obtained when the FHR was within the 130–150 bpm range, aiming to minimize the potential influence of FHR on Doppler indices. As noted in this paragraph, since our study did not include a control group, we were unable to determine whether the observed changes in MCA PI were due to glycemic fluctuations or diurnal variation.
Degani et al. [10] reported increased PI values of the UA and fetal intracranial internal carotid artery one hour after the 100-g OGTT, indicating elevated cerebrovascular resistance due to increased glucose levels. A study conducted with 30 healthy pregnant women between the 24th and 28th weeks of gestation found no significant difference in the S/D and RI values of the UA and uterine artery before and one, two, and three hours after the 100-g OGTT [9]. Similarly, several other studies found no significant change in the UA-PI value after OGTT [8,9,18]. Along these lines, some studies have shown no change in MCA-PI and fetal AC values or AC Z scores due to OGTT [7,15].
Although several studies [7,8,15,16] reported a decrease in the MCA-PI values after the maternal glucose challenge test featuring non-physiological doses, overall, the results of the studies on the impact of the increase in non-physiological maternal glucose levels on fetoplacental and uteroplacental circulation can be considered controversial.
In line with the literature, we found the mean MCA/PI, MCA RI, MCA S/D, CPR values, MCA/PI, and CPR Z scores obtained from the second measurement were significantly lower than those obtained from the first measurement. In parallel with other studies in the literature, the significant decrease we detected in CPR value and CPR Z score was an expected finding, given the decrease in the MCA PI, MCA RI, MCA S/D values and MCA PI-Z score.
Plot MCA-PI vs. gestational age graph is parabolic, featuring a gradual decrease in MCA-PI value in the third trimester [19]. This decrease is associated with a nearly threefold increase in brain weight [20], which leads to higher energy demands and enhanced vascularization in the fetal brain [15,21]. The postprandial decrease in MCA-PI supports brain development by increasing blood and nutrient flow to the brain [16]. Vasodilation is thought to contribute to reducing cerebral vascular resistance, potentially through neural mechanisms and circulating vasoactive agents. One of these mechanisms is the endothelium-dependent L-arginine/nitric oxide pathway [22,23]. Elevated glucose levels within the normal range in human umbilical vein endothelial cell cultures reduce vessel wall tension by stimulating insulin-induced nitric oxide production [24]. High glucose levels also activate nicotinamide adenine dinucleotide phosphate oxidase (NOX), generating significant amounts of reactive oxygen species [24]. Insulin protects endothelial functions against high glucose concentrations by increasing nitric oxide synthesis via human cationic amino acid transporter-1 (hCAT-1). It has been reported that at high D-glucose concentrations, tetrahydrobiopterin levels in human umbilical vein endothelial cells (HUVECs) are not restored by insulin, leading to increased vasoconstriction and decreased vasodilation with higher oxidative stress [24]. Mancusi et al. [25] found no significant difference in the enzyme’s expression, intracellular distribution, or basal activity at either incubation concentration.
Our study included a more significant number of patients than all other relevant studies in the literature. Intra-observer reliability analysis revealed high agreement between the first and second measurements, indicating that our measurements were reliable. Additionally, considering that Doppler indices change according to gestational age, calculating the Z scores of these indices adds more value to our study. To our knowledge, our study is one of the few studies comparing Z scores in this patient population. Our study did not include a control group; we were unable to determine whether the observed changes in MCA PI were due to glycemic fluctuations or diurnal variation.
In conclusion, understanding the impact of maternal glucose levels and insulin on fetoplacental circulation is crucial, given the complexity of the mechanisms involved. Previous studies have often used relatively small samples of pregnant women at varying gestational ages, making it difficult to draw definitive conclusions. Our findings indicate that acute hyperglycemia induced by OGTT significantly affects fetal cerebral circulation, as evidenced by lower MCA/PI, CPR values, and MCA/PI and CPR Z scores, but not uteroplacental circulation. Further large-scale studies are needed to explore different maternal glucose levels and the chronic effects of non-physiological maternal glucose values.

Author Contributions

Conceptualization, H.G.T.Ö.; Software, S.Ü. and B.O.; Validation, H.G.T.Ö. and S.Ü.; Formal analysis, G.A.A., S.Ü. and B.O.; Resources, G.A.A.; Data curation, B.O.; Writing—original draft, H.G.T.Ö.; Writing—review & editing, G.A.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. This study was designed as a prospective single-center study. The study protocol was approved by the Bursa City Hospital Ethics Committee (Decision No: 2021-11/3, approval date: 16 June 2021).

Informed Consent Statement

Written informed consent was obtained from the participants included in the study.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Nicolaides, K.H.; Bilardo, C.M.; Soothill, P.W.; Campbell, S. Absence of end diastolic frequencies in umbilical artery: A sign of fetal hypoxia and acidosis. Br. Med. J. 1988, 297, 1026–1027. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  2. Vyas, S.; Nicolaides, K.H.; Bower, S.; Campbell, S. Middle cerebral artery flow velocity waveforms in fetal hypoxaemia. Br. J. Obstet. Gynaecol. 1990, 97, 797–803. [Google Scholar] [CrossRef] [PubMed]
  3. Bilardo, C.M.; Nicolaides, K.H.; Campbell, S. Doppler measurements of fetal and uteroplacental circulations: Relationship with umbilical venous blood gases measured at cordocentesis. Am. J. Obstet. Gynecol. 1990, 162, 115–120. [Google Scholar] [CrossRef] [PubMed]
  4. Khalil, A.; Morales-Rosello, J.; Khan, N.; Nath, M.; Agarwal, P.; Bhide, A.; Papageorghiou, A.; Thilaganathan, B. Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome? Am. J. Obstet. Gynecol. 2017, 216, 606.e1–606.e10. [Google Scholar] [CrossRef] [PubMed]
  5. Meher, S.; Hernandez-Andrade, E.; Basheer, S.N.; Lees, C. Impact of cerebral redistribution on neurodevelopmental outcome in small-for-gestational-age or growth-restricted babies: A systematic review. Ultrasound Obstet. Gynecol. 2015, 46, 398–404. [Google Scholar] [CrossRef] [PubMed]
  6. Trudinger, B.J.; Giles, W.B.; Cook, C.M.; Bombardieri, J.; Collins, L. Fetal umbilical artery flow velocity waveforms and placental resistance: Clinical significance. Br. J. Obstet. Gynaecol. 1985, 92, 23–30. [Google Scholar] [CrossRef] [PubMed]
  7. Haugen, G.; Bollerslev, J.; Henriksen, T. Human umbilical and fetal cerebral blood flow velocity waveforms following maternal glucose loading: A cross-sectional observational study. Acta Obstet. Gynecol Scand. 2016, 95, 683–689. [Google Scholar] [CrossRef] [PubMed]
  8. Gillis, S.; Connors, G.; Potts, P.; Hunse, C.; Richardson, B. The effect of glucose on Doppler flow velocity waveforms and heart rate pattern in the human fetus. Early Hum. Dev. 1992, 30, 1–10. [Google Scholar] [CrossRef] [PubMed]
  9. Yogev, Y.; Ben-Haroush, A.; Chen, R.; Hod, M.; Merril, Z.; Meizner, I. Doppler sonographic characteristics of umbilical and uterine arteries during oral glucose tolerance testing in healthy pregnant women. J. Clin. Ultrasound 2003, 31, 461–464. [Google Scholar] [CrossRef] [PubMed]
  10. Degani, S. Fetal cerebrovascular circulation: A review of prenatal ultrasound assessment. Gynecol. Obstet. Investig. 2008, 66, 184–196. [Google Scholar] [CrossRef] [PubMed]
  11. Bhide, A.; Acharya, G.; Bilardo, C.M.; Brezinka, C.; Cafici, D.; Hernandez-Andrade, E.; Kalache, K.; Kingdom, J.; Kiserud, T.; Lee, W.; et al. ISUOG practice guidelines: Use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2013, 41, 233–239. [Google Scholar] [CrossRef] [PubMed]
  12. Mari, G. Doppler ultrasonography in obstetrics: From the diagnosis of fetal anemia to the treatment of intrauterine growth-restricted fetuses. Am J Obstet Gynecol. 2009, 200, 613.e1–613.e9. [Google Scholar] [CrossRef] [PubMed]
  13. Arduini, D.; Rizzo, G. Normal values of Pulsatility Index from fetal vessels: A cross-sectional study on 1556 healthy fetuses. J. Perinat. Med. 1990, 18, 165–172. [Google Scholar] [CrossRef] [PubMed]
  14. Rizzo, G.; Rizzo, L.; Aiello, E.; Allegra, E.; Arduini, D. Modelling umbilical vein blood flow normograms at 14-40 weeks of gestation by quantile regression analysis. J. Matern.-Fetal Neonatal Med. 2016, 29, 701–706. [Google Scholar] [CrossRef] [PubMed]
  15. Opheim, G.L.; Zucknick, M.; Henriksen, T.; Haugen, G. A maternal meal affects clinical Doppler parameters in the fetal middle cerebral artery. PLoS ONE 2018, 13, e0209990. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  16. Pardo, J.; Orvieto, R.; Rabinerson, D.; Bar, J.; Hod, M.; Kaplan, B. Fetal middle-cerebral and umbilical artery flow assessments after glucose challenge test. Int. J. Gynaecol. Obstet. 1999, 65, 255–259. [Google Scholar] [CrossRef] [PubMed]
  17. Zahid, S.M.; Opheim, G.L.; Henriksen, T.; Michelsen, T.M.; Haugen, G. Effect of a standardized maternal meal on fetal middle cerebral artery Doppler indices: A single-blinded crossover study. PLoS ONE 2022, 17, e0272062. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  18. Senoh, D.; Hata, T.; Kitao, M. Effect of maternal hyperglycemia on fetal regional circulation in appropriate for gestational age and small for gestational age fetuses. Am. J. Perinatol. 1995, 12, 223–226. [Google Scholar] [CrossRef] [PubMed]
  19. Ebbing, C.; Rasmussen, S.; Kiserud, T. Middle cerebral artery blood flow velocities and pulsatility index and the cerebroplacentalpulsatility ratio: Longitudinal reference ranges and terms for serial measurements. Ultrasound Obstet. Gynecol. 2007, 30, 287–296. [Google Scholar] [CrossRef] [PubMed]
  20. Hüppi, P.S.; Warfield, S.; Kikinis, R.; Barnes, P.D.; Zientara, G.P.; Jolesz, F.A.; Tsuji, M.K.; Volpe, J.J. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann. Neurol. 1998, 43, 224–235. [Google Scholar] [CrossRef] [PubMed]
  21. Du Plessis, A.J. Cerebral blood flow and metabolism in the developing fetus. Clin. Perinatol. 2009, 36, 531–548. [Google Scholar] [CrossRef] [PubMed]
  22. Sobrevia, L.; Nadal, A.; Yudilevich, D.L.; Mann, G.E. Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J. Physiol. 1996, 490 Pt 3, 775–781. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  23. Hunter, C.J.; Blood, A.B.; White, C.R.; Pearce, W.J.; Power, G.G. Role of nitric oxide in hypoxic cerebral vasodilatation in the ovine fetus. J. Physiol. 2003, 549 Pt 2, 625–633. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  24. González, M.; Rojas, S.; Avila, P.; Cabrera, L.; Villalobos, R.; Palma, C.; Aguayo, C.; Peña, E.; Gallardo, V.; Guzmán-Gutiérrez, E.; et al. Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells. PLoS ONE 2015, 10, e0122398. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  25. Mancusi, G.; Hutter, C.; Baumgartner-Parzer, S.; Schmidt, K.; Schütz, W.; Sexl, V. High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase. Biochem. J. 1996, 315 Pt 1, 281–287. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Table 1. Intra-Observer Reliability Results for Uterine Artery Measurements.
Table 1. Intra-Observer Reliability Results for Uterine Artery Measurements.
MeasurementIntraclass Correlation (ICC)Lower BoundUpper Boundp-Values
R UT S/D0.9700.9440.985<0.001
R UT PI0.9670.9370.983<0.001
R UT RI0.9240.8580.960<0.001
L UT S/D0.9430.8940.970<0.001
L UT PI0.9440.8950.971<0.001
L UT RI0.9610.9270.980<0.001
Abbreviations: R UT: Right Uterine Artery, L UT: Left Uterine Artery, S/D: Systolic/Diastolic Ratio, PI: Pulsatility Index, RI: Resistive Index, ICC: Intraclass Correlation.
Table 2. Descriptive Statistics for Study Variables.
Table 2. Descriptive Statistics for Study Variables.
VariablenMean ± SDMedian [Min–Max]25th–75th Percentiles
Age (years)20728.71 ± 5.3928.0 [19–41][25.0–32.0]
Height (cm)209162.09 ± 5.59162.0 [150.0–178.0][158.5–166.0]
Weight (kg)20975.99 ± 13.0674.0 [48.0–116.0][67.0–84.5]
BMI (kg/m2)20928.96 ± 4.9928.20 [19.47–43.66][25.23–32.30]
Pre-pregnancy weight (kg)20968.01 ± 13.2865.0 [40.0–113.0][58.5–75.0]
Gestational week (LMP)20225.43 ± 1.8425.14 [18.71–30.71][24.14–26.61]
Gestational week (US)20925.77 ± 1.9825.43 [19.14–32.14][24.50–27.07]
Birth weight, 1st delivery (g)1283205.63 ± 532.773200.0 [700–4550][2910.0–3590.0]
Birth weight, 2nd delivery (g)553319.27 ± 391.783300.0 [2500–4300][3050.0–3600.0]
Birth weight, 3rd delivery (g)153490.0 ± 562.583300.0 [2500–4650][3100.0–4000.0]
USG/BPD (cm)20925.81 ± 2.2225.40 [19.5–32.0][24.35–27.30]
AC (cm)20925.68 ± 1.9925.50 [19.3–32.6][24.30–27.05]
FL (cm)20925.43 ± 2.1425.30 [19.0–31.4][24.20–26.55]
EFW (g)209981.28 ± 686.45877.0 [271–10,002][765.5–1101.5]
OGTT—0 MIN (mg/dL)20982.69 ± 12.1980.00 [55–139][75.00–88.00]
OGTT—60 MIN (mg/dL)208125.19 ± 29.15121.00 [61–265][106.00–145.75]
Abbreviations: BMI, body mass index; OGTT, oral glucose tolerance test; EFW, estimated fetal weight; LMP, start date of the last menstrual period; US, ultrasound; BPD, biparietal diameter; AC, abdominal circumference; FL, femur length.
Table 3. Demographic and Clinical Characteristics of Study Participants.
Table 3. Demographic and Clinical Characteristics of Study Participants.
Clinical Characteristicn (%)
Systemic disease
Absent186 (89.0)
Present23 (11.0)
Smoking
Absent181 (86.6)
Present28 (13.4)
Regular drug use
Absent194 (92.8)
Present15 (7.2)
Family history of DM
Absent146 (69.9)
Present63 (30.1)
Previous pregnancy DM
Absent203 (97.6)
Present5 (2.4)
Preeclampsia
Absent201 (96.6)
Present7 (3.4)
IUGR
Absent197 (94.7)
Present11 (5.3)
Preterm delivery
Absent198 (95.2)
Present10 (4.8)
Abbreviations: DM: Diabetes Mellitus, IUGR: Intrauterine Growth Restriction.
Table 4. Comparison of Uterine and Umbilical Artery Doppler Indices Between Two Time Points.
Table 4. Comparison of Uterine and Umbilical Artery Doppler Indices Between Two Time Points.
VariablesnMean ± SDp-Values
Right Uterine Artery PI 12090.92 ± 0.380.189
Right Uterine Artery PI 22090.94 ± 0.40
Right Uterine PI-Z Score 1208−0.17 ± 1.370.412
Right Uterine PI-Z Score 2208−0.10 ± 1.48
Right Uterine RI 12090.54 ± 0.110.437
Right Uterine RI 22090.55 ± 0.12
Right Uterine S/D 12092.35 ± 0.780.107
Right Uterine S/D 22092.42 ± 0.95
Left Uterine Artery PI 12090.95 ± 0.310.387
Left Uterine Artery PI 22090.96 ± 0.35
Left Uterine PI-Z Score 12080.08 ± 1.180.464
Left Uterine PI-Z Score 22080.11 ± 1.23
Left Uterine RI 12090.56 ± 0.090.566
Left Uterine RI 22090.56 ± 0.10
Left Uterine S/D 12092.40 ± 0.670.375
Left Uterine S/D 22092.42 ± 0.75
Mean Uterine Artery PI 12090.94 ± 0.280.200
Mean Uterine Artery PI 22090.95 ± 0.31
Mean Uterine PI-Z Score 1209−0.05 ± 1.040.284
Mean Uterine PI-Z Score 22090.00 ± 1.14
Mean Uterine RI 12090.55 ± 0.080.411
Mean Uterine RI 22090.55 ± 0.09
Mean Uterine S/D 12092.37 ± 0.580.129
Mean Uterine S/D 22092.42 ± 0.68
Umbilical Artery PI 12091.10 ± 0.170.901
Umbilical Artery PI 22091.11 ± 0.18
Umbilical Artery PI-Z Score 1208−0.12 ± 1.060.947
Umbilical Artery PI-Z Score 2208−0.12 ± 1.07
Umbilical Artery RI 12090.68 ± 0.060.900
Umbilical Artery RI 22090.68 ± 0.06
Umbilical Artery S/D 12093.26 ± 0.690.898
Umbilical Artery S/D 22093.27 ± 0.70
MCA PI 12091.86 ± 0.37<0.001
MCA PI 22091.74 ± 0.33
MCA PI-Z Score 12080.29 ± 1.25<0.001
MCA PI-Z Score 2208−0.18 ± 1.30
MCA RI 12090.82 ± 0.07<0.001
MCA RI 22090.81 ± 0.07
MCA S/D 12096.77 ± 5.30<0.001
MCA S/D 22095.62 ± 2.46
CPR 12081.73 ± 0.440.004
CPR 22081.61 ± 0.41
Table 5. Comparison of participants with positive and negative 50 g challenge test results in terms of changes observed between the two Doppler measurements.
Table 5. Comparison of participants with positive and negative 50 g challenge test results in terms of changes observed between the two Doppler measurements.
50 gr Challenge TestnMeanSD25thPercentiles 75thp *
Right uterine PI Positive62−0.04480.32783−0.2325−0.04000.10500.477
Negative147−0.00310.29899−0.1700−0.01000.1400
Right uterine RI Positive62−0.00870.09943−0.0625−0.02000.05250.481
Negative147−0.00200.09712−0.060000.0500
Right uterine S/D Positive62−0.20310.93840−0.4225−0.07000.20250.320
Negative147−0.01540.58621−0.2900−0.01000.2000
Left uterine PIPositive620.06730.27043−0.100000.21250.014
Negative147−0.05100.27818−0.1700−0.04000.1000
Left uterine RIPositive620.02400.08921−0.03000.02000.08250.013
Negative147−0.01400.07742−0.0600−0.01000.0400
Left uterine S/DPositive620.18810.72193−0.16250.10500.39250.004
Negative147−0.12010.62294−0.3500−0.06000.2000
Umbilical artery PI Positive620.01550.18471−0.12500.01000.16250.367
Negative147−0.01140.19055−0.1200−0.02000.1200
Umbilical artery RI Positive620.00810.07310000.10000.377
Negative147−0.00140.07401000
Umbilical artery S/D Positive620.16530.80181−0.37500.04500.66500.333
Negative147−0.00240.74007−0.370000.4200
*: Mann–Whitney U test.
Table 6. Comparison of participants with positive and negative 100 g OGTT results in terms of changes observed between the two Doppler measurements.
Table 6. Comparison of participants with positive and negative 100 g OGTT results in terms of changes observed between the two Doppler measurements.
Test ResultnMeanSD25thPercentiles Median75thp *
Right uterine PI Positive70.01000.18276−0.14000.03000.18000.662
Negative174−0.01860.29681−0.1900−0.02500.1325
Right uterine RIPositive70.00290.05407−0.0300−0.02000.06000.897
Negative174−0.00540.09539−0.060000.0500
Right uterine S/D Positive7−0.09000.38850−0.3500−0.18000.22000.791
Negative174−0.06070.65831−0.3100−0.02500.2000
Left uterine PI Positive70.13290.15934−0.09000.18000.25000.042
Negative174−0.03120.28155−0.1700−0.02000.1125
Left uterine RI Positive70.04710.06576−0.04000.07000.09000.048
Negative174−0.00860.07981−0.0600−0.01000.0425
Left uterine S/D Positive70.27290.37518−0.19000.39000.49000.037
Negative174−0.07030.65948−0.3225−0.05000.2225
Umbilical artery PI Positive70.08290.13413−0.05000.09000.24000.176
Negative174−0.00790.19181−0.1200−0.01000.1200
Umbilical artery RI Positive70.04290.05345000.10000.135
Negative1740.00170.07486000.1000
Umbilical artery S/DPositive70.22430.47017−0.15000.22000.75000.429
Negative1740.02000.74920−0.35000.01000.4425
*: Mann–Whitney U test.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Turan Özsoy, H.G.; Adanaş Aydın, G.; Ünal, S.; Oral, B. Impact of 50 g OGTT-Induced Acute Hyperglycemia on Uteroplacental and Fetoplacental Circulations in Gestational Diabetes Screening: A Prospective Single-Center Study. J. Clin. Med. 2025, 14, 8362. https://doi.org/10.3390/jcm14238362

AMA Style

Turan Özsoy HG, Adanaş Aydın G, Ünal S, Oral B. Impact of 50 g OGTT-Induced Acute Hyperglycemia on Uteroplacental and Fetoplacental Circulations in Gestational Diabetes Screening: A Prospective Single-Center Study. Journal of Clinical Medicine. 2025; 14(23):8362. https://doi.org/10.3390/jcm14238362

Chicago/Turabian Style

Turan Özsoy, Hilal Gülsüm, Gültekin Adanaş Aydın, Serhat Ünal, and Behiye Oral. 2025. "Impact of 50 g OGTT-Induced Acute Hyperglycemia on Uteroplacental and Fetoplacental Circulations in Gestational Diabetes Screening: A Prospective Single-Center Study" Journal of Clinical Medicine 14, no. 23: 8362. https://doi.org/10.3390/jcm14238362

APA Style

Turan Özsoy, H. G., Adanaş Aydın, G., Ünal, S., & Oral, B. (2025). Impact of 50 g OGTT-Induced Acute Hyperglycemia on Uteroplacental and Fetoplacental Circulations in Gestational Diabetes Screening: A Prospective Single-Center Study. Journal of Clinical Medicine, 14(23), 8362. https://doi.org/10.3390/jcm14238362

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop